BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 18726920)

  • 1. Risk prediction of fever in neutropenia in children with cancer: a step towards individually tailored supportive therapy?
    Wicki S; Keisker A; Aebi C; Leibundgut K; Hirt A; Ammann RA
    Pediatr Blood Cancer; 2008 Dec; 51(6):778-83. PubMed ID: 18726920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deficiency of mannose-binding lectin-associated serine protease-2 associated with increased risk of fever and neutropenia in pediatric cancer patients.
    Schlapbach LJ; Aebi C; Otth M; Leibundgut K; Hirt A; Ammann RA
    Pediatr Infect Dis J; 2007 Nov; 26(11):989-94. PubMed ID: 17984804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum levels of mannose-binding lectin and the risk of fever in neutropenia pediatric cancer patients.
    Schlapbach LJ; Aebi C; Otth M; Luethy AR; Leibundgut K; Hirt A; Ammann RA
    Pediatr Blood Cancer; 2007 Jul; 49(1):11-6. PubMed ID: 17143875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting bacteremia in children with cancer and fever in chemotherapy-induced neutropenia: results of the prospective multicenter SPOG 2003 FN study.
    Agyeman P; Aebi C; Hirt A; Niggli FK; Nadal D; Simon A; Ozsahin H; Kontny U; Kühne T; Beck Popovic M; Leibundgut K; Bodmer N; Ammann RA
    Pediatr Infect Dis J; 2011 Jul; 30(7):e114-9. PubMed ID: 21394050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of children presenting with fever in chemotherapy-induced neutropenia at low risk for severe bacterial infection.
    Ammann RA; Hirt A; Lüthy AR; Aebi C
    Med Pediatr Oncol; 2003 Nov; 41(5):436-43. PubMed ID: 14515382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting adverse events in children with fever and chemotherapy-induced neutropenia: the prospective multicenter SPOG 2003 FN study.
    Ammann RA; Bodmer N; Hirt A; Niggli FK; Nadal D; Simon A; Ozsahin H; Kontny U; Kühne T; Popovic MB; Lüthy AR; Aebi C
    J Clin Oncol; 2010 Apr; 28(12):2008-14. PubMed ID: 20231680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting bacteremia in children with fever and chemotherapy-induced neutropenia.
    Ammann RA; Hirt A; Lüthy AR; Aebi C
    Pediatr Infect Dis J; 2004 Jan; 23(1):61-7. PubMed ID: 14743049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different fever definitions and the rate of fever and neutropenia diagnosed in children with cancer: a retrospective two-center cohort study.
    Binz P; Bodmer N; Leibundgut K; Teuffel O; Niggli FK; Ammann RA
    Pediatr Blood Cancer; 2013 May; 60(5):799-805. PubMed ID: 23193083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk index score for bacteremia in febrile neutropenic episodes in children with malignancies.
    Spasova MI; Grudeva-Popova JG; Kostyanev SS; Genev ED; Stoyanova AA; Kirina VI; Moumdjiev IN
    J BUON; 2009; 14(3):411-8. PubMed ID: 19810131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early lymphopenia as a risk factor for chemotherapy-induced febrile neutropenia.
    Choi CW; Sung HJ; Park KH; Yoon SY; Kim SJ; Oh SC; Seo JH; Kim BS; Shin SW; Kim YH; Kim JS
    Am J Hematol; 2003 Aug; 73(4):263-6. PubMed ID: 12879430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serious medical complications in children with cancer and fever in chemotherapy-induced neutropenia: results of the prospective multicenter SPOG 2003 FN study.
    Lüthi F; Leibundgut K; Niggli FK; Nadal D; Aebi C; Bodmer N; Ammann RA
    Pediatr Blood Cancer; 2012 Jul; 59(1):90-5. PubMed ID: 21837771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prospective study on the epidemiology of febrile episodes during chemotherapy-induced neutropenia in children with cancer or after hemopoietic stem cell transplantation.
    Castagnola E; Fontana V; Caviglia I; Caruso S; Faraci M; Fioredda F; Garrè ML; Moroni C; Conte M; Losurdo G; Scuderi F; Bandettini R; Tomà P; Viscoli C; Haupt R
    Clin Infect Dis; 2007 Nov; 45(10):1296-304. PubMed ID: 17968824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Which one is a risk factor for chemotherapy-induced febrile neutropenia in childhood solid tumors: early lymphopenia or monocytopenia?
    Oguz A; Karadeniz C; Ckitak EC; Cil V
    Pediatr Hematol Oncol; 2006 Mar; 23(2):143-51. PubMed ID: 16651243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of febrile neutropenia episodes in children with acute leukemia treated with BFM protocols.
    Yilmaz S; Oren H; Demircioğlu F; Irken G
    Pediatr Hematol Oncol; 2008; 25(3):195-204. PubMed ID: 18432502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Consensus: Rational approach towards the patient with cancer, fever and neutropenia].
    Santolaya ME; Rabagliati R; Bidart T; Payá E; Guzmán AM; Morales R; Braun S; Bronfman L; Ferrés M; Flores C; García P; Letelier LM; Puga B; Salgado C; Thompson L; Tordecilla J; Zubieta M; ;
    Rev Chilena Infectol; 2005; 22 Suppl 2():S79-113. PubMed ID: 16311689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk prediction in pediatric cancer patients with fever and neutropenia.
    Hakim H; Flynn PM; Srivastava DK; Knapp KM; Li C; Okuma J; Gaur AH
    Pediatr Infect Dis J; 2010 Jan; 29(1):53-9. PubMed ID: 19996816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting fever in neutropenia with safety-relevant events in children undergoing chemotherapy for cancer: The prospective multicenter SPOG 2015 FN Definition Study.
    Lavieri L; Koenig C; Bodmer N; Agyeman PKA; Scheinemann K; Ansari M; Roessler J; Ammann RA
    Pediatr Blood Cancer; 2021 Dec; 68(12):e29253. PubMed ID: 34310027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. First-day step-down to oral outpatient treatment versus continued standard treatment in children with cancer and low-risk fever in neutropenia. A randomized controlled trial within the multicenter SPOG 2003 FN study.
    Brack E; Bodmer N; Simon A; Leibundgut K; Kühne T; Niggli FK; Ammann RA
    Pediatr Blood Cancer; 2012 Sep; 59(3):423-30. PubMed ID: 22271702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retrospective cost analysis of management of febrile neutropenia in cancer patients in Spain.
    Mayordomo JI; López A; Viñolas N; Castellanos J; Pernas S; Domingo Alonso J; Frau A; Layola M; Antonio Gasquet J; Sánchez J;
    Curr Med Res Opin; 2009 Oct; 25(10):2533-42. PubMed ID: 19722781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pediatric patients at risk for fever in chemotherapy-induced neutropenia in Bern, Switzerland, 1993-2012.
    von Allmen AN; Zermatten MG; Leibundgut K; Agyeman P; Ammann RA
    Sci Data; 2018 Mar; 5():180038. PubMed ID: 29534058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.